These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
529 related articles for article (PubMed ID: 17420348)
1. Adherence to statin therapy under drug cost sharing in patients with and without acute myocardial infarction: a population-based natural experiment. Schneeweiss S; Patrick AR; Maclure M; Dormuth CR; Glynn RJ Circulation; 2007 Apr; 115(16):2128-35. PubMed ID: 17420348 [TBL] [Abstract][Full Text] [Related]
2. Impact of two sequential drug cost-sharing policies on the use of inhaled medications in older patients with chronic obstructive pulmonary disease or asthma. Dormuth CR; Glynn RJ; Neumann P; Maclure M; Brookhart AM; Schneeweiss S Clin Ther; 2006 Jun; 28(6):964-78; discussion 962-3. PubMed ID: 16860179 [TBL] [Abstract][Full Text] [Related]
3. Association between copayment and adherence to statin treatment initiated after coronary heart disease hospitalization: a longitudinal, retrospective, cohort study. Ye X; Gross CR; Schommer J; Cline R; St Peter WL Clin Ther; 2007 Dec; 29(12):2748-57. PubMed ID: 18201593 [TBL] [Abstract][Full Text] [Related]
4. Results of a retrospective database analysis of adherence to statin therapy and risk of nonfatal ischemic heart disease in daily clinical practice in Italy. Corrao G; Conti V; Merlino L; Catapano AL; Mancia G Clin Ther; 2010 Feb; 32(2):300-10. PubMed ID: 20206788 [TBL] [Abstract][Full Text] [Related]
5. Lowering copayments: impact of simvastatin patent expiration on patient adherence. Sedjo RL; Cox ER Am J Manag Care; 2008 Dec; 14(12):813-8. PubMed ID: 19067498 [TBL] [Abstract][Full Text] [Related]
6. Impact of statin copayments on adherence and medical care utilization and expenditures. Gibson TB; Mark TL; Axelsen K; Baser O; Rublee DA; McGuigan KA Am J Manag Care; 2006 Dec; 12 Spec no.():SP11-9. PubMed ID: 17173486 [TBL] [Abstract][Full Text] [Related]
7. Adherence to beta-blocker therapy under drug cost-sharing in patients with and without acute myocardial infarction. Schneeweiss S; Patrick AR; Maclure M; Dormuth CR; Glynn RJ Am J Manag Care; 2007 Aug; 13(8):445-52. PubMed ID: 17685825 [TBL] [Abstract][Full Text] [Related]
8. Long-term persistence with statin treatment in a not-for-profit health maintenance organization: a population-based retrospective cohort study in Israel. Chodick G; Shalev V; Gerber Y; Heymann AD; Silber H; Simah V; Kokia E Clin Ther; 2008 Nov; 30(11):2167-79. PubMed ID: 19108805 [TBL] [Abstract][Full Text] [Related]
9. Should patients receive secondary prevention medications for free after a myocardial infarction? An economic analysis. Choudhry NK; Avorn J; Antman EM; Schneeweiss S; Shrank WH Health Aff (Millwood); 2007; 26(1):186-94. PubMed ID: 17211028 [TBL] [Abstract][Full Text] [Related]
10. Pharmacoutilization of statin therapy after acute myocardial infarction. A real practice analysis based on administrative data. Degli Esposti L; Di Martino M; Saragoni S; Valpiani G; Capone A; Corvi E; Degli Esposti E Ital Heart J; 2004 Feb; 5(2):120-6. PubMed ID: 15086141 [TBL] [Abstract][Full Text] [Related]
11. Adherence to statins, beta-blockers and angiotensin-converting enzyme inhibitors following a first cardiovascular event: a retrospective cohort study. Blackburn DF; Dobson RT; Blackburn JL; Wilson TW; Stang MR; Semchuk WM Can J Cardiol; 2005 May; 21(6):485-8. PubMed ID: 15917876 [TBL] [Abstract][Full Text] [Related]
12. The impact of reducing cardiovascular medication copayments on health spending and resource utilization. Choudhry NK; Fischer MA; Avorn JL; Lee JL; Schneeweiss S; Solomon DH; Berman C; Jan S; Lii J; Mahoney JJ; Shrank WH J Am Coll Cardiol; 2012 Oct; 60(18):1817-24. PubMed ID: 23040581 [TBL] [Abstract][Full Text] [Related]
13. Patient adherence to generic versus brand statin therapy after acute myocardial infarction: Insights from the Can Rapid Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the American College of Cardiology/American Heart Association Guidelines Registry. O'Brien EC; McCoy LA; Thomas L; Peterson ED; Wang TY Am Heart J; 2015 Jul; 170(1):55-61. PubMed ID: 26093864 [TBL] [Abstract][Full Text] [Related]
14. The demand for statin: the effect of copay on utilization and compliance. Thiebaud P; Patel BV; Nichol MB Health Econ; 2008 Jan; 17(1):83-97. PubMed ID: 17585395 [TBL] [Abstract][Full Text] [Related]
15. Effect of copayments on drug use in the presence of annual payment limits. Kephart G; Skedgel C; Sketris I; Grootendorst P; Hoar J Am J Manag Care; 2007 Jun; 13(6 Pt 2):328-34. PubMed ID: 17567233 [TBL] [Abstract][Full Text] [Related]
16. Cardiovascular morbidity associated with nonadherence to statin therapy. Blackburn DF; Dobson RT; Blackburn JL; Wilson TW Pharmacotherapy; 2005 Aug; 25(8):1035-43. PubMed ID: 16207093 [TBL] [Abstract][Full Text] [Related]
17. Clinical and economic consequences of reference pricing for dihydropyridine calcium channel blockers. Schneeweiss S; Soumerai SB; Maclure M; Dormuth C; Walker AM; Glynn RJ Clin Pharmacol Ther; 2003 Oct; 74(4):388-400. PubMed ID: 14534526 [TBL] [Abstract][Full Text] [Related]
18. Impact of drug cost sharing on service use and adverse clinical outcomes in elderly receiving antidepressants. Wang PS; Patrick AR; Dormuth C; Maclure M; Avorn J; Canning CF; Schneeweiss S J Ment Health Policy Econ; 2010 Mar; 13(1):37-44. PubMed ID: 20571181 [TBL] [Abstract][Full Text] [Related]
19. Pattern of statin use among 10 cohorts of new users from 1995 to 2004: a register-based nationwide study. Helin-Salmivaara A; Lavikainen PT; Korhonen MJ; Halava H; Martikainen JE; Saastamoinen LK; Virta L; Klaukka T; Huupponen R Am J Manag Care; 2010 Feb; 16(2):116-22. PubMed ID: 20148616 [TBL] [Abstract][Full Text] [Related]
20. Assessing the effect of Taiwan's outpatient prescription drug copayment policy in the elderly. Liu SZ; Romeis JC Med Care; 2003 Dec; 41(12):1331-42. PubMed ID: 14668666 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]